Robert M. Eisner

Robert M. Eisner

Hematology | Oncology | Palliative Medicine

2180 Pfingsten Rd.
Kellogg Cancer Center
Glenview, IL 60026

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Intravenous Immunoglobulin Induces Sustained Hemostatic Responses in IgM Paraprotein-Associated Acquired Von Willebrand Syndrome.

Intravenous Immunoglobulin Induces Sustained Hemostatic Responses in IgM Paraprotein-Associated Acquired Von Willebrand Syndrome.

Journal: Cureus

Published: July 08, 2026

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.

Journal: Blood advances

Published: February 24, 2025

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.

Journal: Blood advances

Published: July 07, 2022

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.

Journal: Blood

Published: June 05, 2020

Showing 1-4 of 4

Last Updated: 09/26/2026